LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study

Authors :: Charles S. Landis
Robert J. Fontana
Eugene R. Schiff
Eric Hughes
Rong Yang
Stephanie Noviello
Fiona McPhee
John M. Vierling
Fred Poordad
Eugene S. Swenson
Source :: Journal of Hepatology. 62:S261-S262
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: medicine.medical_specialty
Daclatasvir
Hepatology
Sofosbuvir
business.industry
Ribavirin
Advanced cirrhosis
Gastroenterology
chemistry.chemical_compound
chemistry
Internal medicine
medicine
business
medicine.drug

Tools